X
Hear from five Nobel-winning scientists (for free) at Curious2018 – Future Insight
https://pharmaphorum.com/partner-content/hear-five-nobel-winning-scientists-free-curious2018-future-insight/
Merck
Need for leaders as Value & Access plays increasing role in pharma
Ana Céspedes, senior vice president of global marketing and strategy at EMD Serono, on the evolution of the Value & Access function.
Merck funds Antidote’s clinical trial matching tech
Funding will go toward expansion of platform capabilities.
ASCO 2017: Breast cancer next target for Keytruda
Immunotherapy combinations will be the focus – but attention is shifting towards these agents proving their overall survival benefits.
The cancer challenge: the quest for a cure is only half the battle
The cancer challenge is affecting more and more people worldwide, with 21 million cases expected by 2030.
Trump demands cuts to ‘astronomical’ drug prices – but pharma reassured
Trump calls pharma leaders to White House to discuss cutting taxes, regulations – and drug prices
Cancer market commentary: Roche’s Tecentriq muscles into NSCLC
Roche’s PD-L1 drug has generated impressive data in second line lung cancer
1 2
